Abstract: An antenna alignment apparatus includes a first antenna alignment unit. The first antenna alignment unit may include: a flange coupled to a transmit antenna jig providing two-axis rotational motion; a first bearing coupled to the flange; a cylinder inserted into the first bearing to rotate; an optical fiber collimator inserted into and aligned with the cylinder and having a variable focal length; an optical fiber mounted on the optical fiber collimator; and a plurality of screws contacting an external side surface of the optical fiber collimator through an external side surface of the cylinder and aligning a central axis of the optical fiber collimator and a central axis of the cylinder.

Abstract: A wavelength conversion device includes a nonlinear optical crystal, a guide light source configured to provide a guide light traveling in a first direction within the nonlinear optical crystal such that a thermal waveguide penetrating the nonlinear optical crystal is formed, a signal light source configured to provide a signal light having a first wavelength (?1) and traveling in a second direction opposite to the first direction through the thermal waveguide, and a pump light source configured to provide a pump light having a second wavelength (?2) and traveling in the second direction through the thermal waveguide, wherein an output light including a wavelength component corresponding to a sum of energies of the first wavelength (?1) and the second wavelength (?2) is provided from the thermal waveguide.

Abstract: The present disclosure relates to a vapor cell and a vapor cell temperature control system, and more specifically, to a vapor cell and a vapor cell temperature control system which use a laser to control the temperature of the vapor cell without distortion of an electromagnetic field. The vapor cell according to an embodiment of the present disclosure may include a body provided with a penetration part, which is a space in which a reactive material is accommodated, and a black material provided on a part of an outer surface of the body. According to an embodiment of the present disclosure, there is an advantage in that the intensity and phase of electromagnetic waves in the micromagnetic field and millimeter wave band can be measured by minimizing distortion and removing noise caused by a temperature control device when measuring electromagnetic fields using an atomic system.

Abstract: The present disclosure relates to an electromagnetically induced grating-based electric field detection system and method and, more particularly, to an electric field detection system and method which enable the creation of an electromagnetically induced transparency grating using a low-wavelength laser and enables real-time electromagnetic wave measurement by avoiding the frequency reprocessing of the signal that is essential in the existing Rydberg atom-based electric field measurement technology.

Abstract: A tacrolimus drug-eluting stent manufacturing method according to the present invention enables a tacrolimus drug to be strongly and stably bound onto a stent, while also not necessarily involving a separate step of introducing a surface-binding functional group for the binding of a drug onto a stent and a step of introducing, into the drug, a functional group capable of binding to the surface-binding functional group, and a tacrolimus drug-eluting stent manufactured by the manufacturing method has a greater total drug elution amount and has a more excellent delayed drug-elution property.

Abstract: A tacrolimus drug-eluting stent manufacturing method according to the present invention enables a tacrolimus drug to be strongly and stably bound onto a stent, while also not necessarily involving a separate step of introducing a surface-binding functional group for the binding of a drug onto a stent and a step of introducing, into the drug, a functional group capable of binding to the surface-binding functional group, and a tacrolimus drug-eluting stent manufactured by the manufacturing method has a greater total drug elution amount and has a more excellent delayed drug-elution property.

Abstract: Provided is a drug-eluting coronary stent. In the drug-eluting coronary stent according to the present invention, electrospinning is used, thereby making it possible to precisely control a total content of an everolimus-based drug bound thereto and form a uniform layer in spite of not using a polymer causing late thrombosis, or the like.

Abstract: Provided are a stent in which a surface of a stent strut is treated by femtosecond laser radiation and is modified by a natural polymer and a method of preparing the stent. The stent and the preparing method may inhibit restenosis and stimulate reendothelialization.

Abstract: Provided is a drug-eluting coronary stent. In the drug-eluting coronary stent according to the present invention, electrospinning is used, thereby making it possible to precisely control a total content of an everolimus-based drug bound thereto and form a uniform layer in spite of not using a polymer causing late thrombosis, or the like.

Abstract: Provided is a drug-eluting coronary stent. In the drug-eluting coronary stent according to the present invention, electrospinning is used, thereby making it possible to precisely control a total content of an everolimus-based drug bound thereto and form a uniform layer in spite of not using a polymer causing late thrombosis, or the like.

Abstract: Provided are a stent in which a surface of a stent strut is treated by femtosecond laser radiation and is modified by a natural polymer and a method of preparing the stent. The stent and the preparing method may inhibit restenosis and stimulate reendothelialization.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Provided are a peptide compound prepared by additional synthesis in a drug having an effect of inhibiting restenosis, a composition for inhibiting restenosis and promoting re-endothelialization including the peptide compound, and a stent having a surface coated by using the composition, in order to overcome a restenosis problem in the stent.

Abstract: Disclosed is a burnable absorber-integrated control rod guide thimble that guides an up-and-down motion of a control rod provided to control reactivity of a reactor core. The control rod guide thimble includes burnable absorbers.

Abstract: There is disclosed a movement sensing device configured to detect movement of an object on a touch region three or more proximity sensors arranged on one surface adjacent to the touch region independently and two-dimensionally, to measure electrical scalars corresponding to distances with the object on the touch region, respectively; and a control unit configured to calculate a vector of a second touch point relatively changed with respect to a first touch point based on a first electrical scalar and a second electrical scalar measured at a predetermined time difference, wherein a relative moving signal with respect to a reference point is generated by calculating the movement of the object as the vector.